{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:51:35Z","timestamp":1785822695018,"version":"3.56.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ejpb.2009.03.010","type":"journal-article","created":{"date-parts":[[2009,4,10]],"date-time":"2009-04-10T08:23:18Z","timestamp":1239351798000},"page":"546-551","source":"Crossref","is-referenced-by-count":16,"title":["Subconjunctivally injected, liposome-encapsulated streptokinase enhances the absorption rate of subconjunctival hemorrhages in rabbits"],"prefix":"10.1016","volume":"72","author":[{"given":"Seung-Hee","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Eon","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Kook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Min","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2009.03.010_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thromres.2003.08.029","article-title":"Platelet activity and antibody titers after exposure to streptokinase or streptococcal infection","volume":"111","author":"Courval","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejpb.2009.03.010_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1583\/04-1438.1","article-title":"Thrombolytic therapies: the current state of affairs","volume":"12","author":"Perler","year":"2005","journal-title":"J. Endovasc. Ther."},{"key":"10.1016\/j.ejpb.2009.03.010_bib3","series-title":"Cecil Textbook of Medicine","first-page":"1021","article-title":"Antithrombotic therapy","author":"Harker","year":"2002"},{"key":"10.1016\/j.ejpb.2009.03.010_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02975283","article-title":"Prolonged systemic delivery of streptokinase using liposome","volume":"21","author":"Kim","year":"1998","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejpb.2009.03.010_bib5","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1167\/iovs.05-1345","article-title":"Effect of subconjunctivally injected, liposome-bound, low-molecular-weight heparin on the absorption rate of subconjunctival hemorrhage in rabbits","volume":"47","author":"Moon","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2009.03.010_bib6","first-page":"59","article-title":"Subconjunctival hemorrhage: treatment with air therapy","volume":"44","author":"Richards","year":"1965","journal-title":"Eye Ear Nose Throat Mon."},{"key":"10.1016\/j.ejpb.2009.03.010_bib7","first-page":"3216","article-title":"Tobramycin liposomes: single subconjunctival therapy of pseudomonal keratitis","volume":"32","author":"Assil","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2009.03.010_bib8","first-page":"486","article-title":"Pharmacokinetics of subconjunctival liposome-encapsulated gentamicin in normal rabbit eyes","volume":"25","author":"Barza","year":"1984","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2009.03.010_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0005-2736(85)90084-7","article-title":"Solute distributions and trapping efficiencies observed in freeze\u2013thawed multilamellar vesicles","volume":"817","author":"Mayer","year":"1985","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2009.03.010_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/clpt.1987.32","article-title":"Pharmacokinetics of streptokinase in patients based on amidolytic activator complex activity","volume":"41","author":"Grierson","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2009.03.010_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1472-8206.2003.00181.x","article-title":"Assessing immunotoxicity: guidelines","volume":"17","author":"Putman","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2009.03.010_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/hrt.68.11.449","article-title":"Streptokinase resistance: when might streptokinase administration be ineffective?","volume":"68","author":"Buchalter","year":"1992","journal-title":"Br. Heart. J."},{"key":"10.1016\/j.ejpb.2009.03.010_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0140-6736(90)90276-B","article-title":"Antistreptokinase titres after intravenous streptokinase","volume":"335","author":"Jalihal","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2009.03.010_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00003495-197305050-00002","article-title":"Streptokinase: a review of its clinical, pharmacology, mechanism of action and therapeutic uses","volume":"5","author":"Brogden","year":"1973","journal-title":"Drugs"},{"key":"10.1016\/j.ejpb.2009.03.010_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0161-6420(93)31639-8","article-title":"Intraocular tissue plasminogen activator concentrations after subconjunctival delivery","volume":"100","author":"Lim","year":"1993","journal-title":"Opthalmology"},{"key":"10.1016\/j.ejpb.2009.03.010_bib16","first-page":"2891","article-title":"Liposome suppression of proliferative vitreoretinopathy. Rabbit model using antimetabolite encapsulated liposomes","volume":"32","author":"Assil","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2009.03.010_bib17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0014-4835(77)90136-1","article-title":"Diffusion across the sclera","volume":"25","author":"Maurice","year":"1977","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2009.03.010_bib18","first-page":"1893","article-title":"Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning","volume":"36","author":"Olsen","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2009.03.010_bib19","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM197912063012305","article-title":"Current concepts: guidelines for the use of thrombolytic agents","volume":"301","author":"Bell","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2009.03.010_bib20","series-title":"Goodman and Gilman\u2019s the Pharmacological Basis of Therapeutics","first-page":"1353","article-title":"Anticoagulant, antithrombotic, and thrombolytic drugs","author":"O\u2019Reilly","year":"1985"},{"key":"10.1016\/j.ejpb.2009.03.010_bib21","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/0140-6736(93)90744-2","article-title":"Antistreptokinase titres after topical streptokinase","volume":"341","author":"Green","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2009.03.010_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2796.2002.01049.x","article-title":"The effect of streptokinase neutralizing antibodies on fibrinolytic activity and reperfusion following streptokinase treatment in acute myocardial infarction","volume":"252","author":"Nilsson","year":"2002","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejpb.2009.03.010_bib23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/00007611-199811000-00005","article-title":"Serum antibody titers in a systemic lytic therapy with streptokinase","volume":"91","author":"Hohage","year":"1998","journal-title":"South. Med. J."},{"key":"10.1016\/j.ejpb.2009.03.010_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/pgmj.72.847.290","article-title":"The distribution of antibodies to streptokinase","volume":"72","author":"Lynch","year":"1996","journal-title":"Postgrad. Med. J."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964110900109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964110900109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T14:30:55Z","timestamp":1545316255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964110900109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S093964110900109X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2009.03.010","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}